Found: 150
Select item for more details and to access through your institution.
Systematic multiomics analysis and in vitro experiments suggest that ITGA5 could serve as a promising therapeutic target for ccRCC.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03546-4
- By:
- Publication type:
- Article
PRIORITI: Phase 4 study of triptorelin or active surveillance in high‐risk prostate cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2024, v. 20, n. 6, p. 738, doi. 10.1111/ajco.14101
- By:
- Publication type:
- Article
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17451, doi. 10.1007/s00432-023-05259-z
- By:
- Publication type:
- Article
Role of KIT expression in the prognosis of clear cell renal cell carcinomas in Chinese patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 2, p. 249, doi. 10.1007/s00432-008-0447-6
- By:
- Publication type:
- Article
Reconstruction with scrotal skin flaps after wide local resection of penoscrotal extramammary Paget's disease.
- Published in:
- BJU International, 2012, v. 110, n. 11c, p. E1121, doi. 10.1111/j.1464-410X.2012.11491.x
- By:
- Publication type:
- Article
Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 11b, p. E667, doi. 10.1111/j.1464-410X.2012.11465.x
- By:
- Publication type:
- Article
The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 11, p. N.PAG, doi. 10.15252/emmm.201910659
- By:
- Publication type:
- Article
B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01390-4
- By:
- Publication type:
- Article
Tertiary Lymphoid Structures Localization and Maturation Heterogeneities Correlate with Divergent Microenvironment Features and Immune Responses of Clear Cell Renal Cell Carcinoma.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 227, doi. 10.36401/JIPO-24-X2
- By:
- Publication type:
- Article
Editorial: The mechanism of tumor evolution and microenvironmental changes of genitourinary oncology in clinical diagnosis and treatment.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272984
- By:
- Publication type:
- Article
Genomic alteration of MTAP/ CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.953721
- By:
- Publication type:
- Article
Immunogenomic Characteristics of Cell-Death-Associated Genes with Prognostic Implications in Bladder Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.909324
- By:
- Publication type:
- Article
Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.734646
- By:
- Publication type:
- Article
SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26049-6
- By:
- Publication type:
- Article
Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231220506
- By:
- Publication type:
- Article
Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231187205
- By:
- Publication type:
- Article
Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 5, p. 1435, doi. 10.1245/s10434-016-5702-5
- By:
- Publication type:
- Article
SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0809-0
- By:
- Publication type:
- Article
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.
- Published in:
- Nature Genetics, 2012, v. 44, n. 11, p. 1231, doi. 10.1038/ng.2424
- By:
- Publication type:
- Article
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 3, p. 144, doi. 10.1111/ajco.13142
- By:
- Publication type:
- Article
Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01682-w
- By:
- Publication type:
- Article
Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma.
- Published in:
- Scientific Reports, 2016, p. 23594, doi. 10.1038/srep23594
- By:
- Publication type:
- Article
Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population.
- Published in:
- Scientific Reports, 2016, p. 21677, doi. 10.1038/srep21677
- By:
- Publication type:
- Article
The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma.
- Published in:
- Scientific Reports, 2016, p. 20089, doi. 10.1038/srep20089
- By:
- Publication type:
- Article
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130308
- By:
- Publication type:
- Article
Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120159
- By:
- Publication type:
- Article
Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118022
- By:
- Publication type:
- Article
Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12395-3
- By:
- Publication type:
- Article
Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01729-7
- By:
- Publication type:
- Article
Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 10, p. 2165, doi. 10.1007/s00345-018-2603-1
- By:
- Publication type:
- Article
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
- Published in:
- World Journal of Urology, 2017, v. 35, n. 3, p. 379, doi. 10.1007/s00345-016-1928-x
- By:
- Publication type:
- Article
Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1541, doi. 10.1007/s00262-022-03347-6
- By:
- Publication type:
- Article
Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1923, doi. 10.1007/s00262-021-03123-y
- By:
- Publication type:
- Article
The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 623, doi. 10.3390/jcm12020623
- By:
- Publication type:
- Article
Comprehensive Collection of Whole-Slide Images and Genomic Profiles for Patients with Bladder Cancer.
- Published in:
- Scientific Data, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41597-024-03526-3
- By:
- Publication type:
- Article
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00465-w
- By:
- Publication type:
- Article
Construction of an Immune Escape-Related Signature in Clear Cell Renal Cell Carcinoma and Identification of the Relationship between IFNAR1 and Immune Infiltration by Multiple Immunohistochemistry.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 169, doi. 10.3390/cancers15010169
- By:
- Publication type:
- Article
Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 831, doi. 10.3390/cancers12040831
- By:
- Publication type:
- Article
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 10, p. 2183, doi. 10.1002/1878-0261.13511
- By:
- Publication type:
- Article
The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 4011, doi. 10.1002/1878-0261.13320
- By:
- Publication type:
- Article
Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study.
- Published in:
- World Journal of Surgical Oncology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12957-015-0597-3
- By:
- Publication type:
- Article
Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study.
- Published in:
- World Journal of Surgical Oncology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12957-015-0561-2
- By:
- Publication type:
- Article
Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer.
- Published in:
- World Journal of Surgical Oncology, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1477-7819-12-14
- By:
- Publication type:
- Article
Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Steroid 5-alpha-reductase type 2 ( SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.
- Published in:
- Molecular Biology Reports, 2013, v. 40, n. 5, p. 3597, doi. 10.1007/s11033-012-2434-x
- By:
- Publication type:
- Article
Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis.
- Published in:
- International Urology & Nephrology, 2020, v. 52, n. 1, p. 87, doi. 10.1007/s11255-019-02294-z
- By:
- Publication type:
- Article
Integration Analysis of Single‐Cell Multi‐Omics Reveals Prostate Cancer Heterogeneity.
- Published in:
- Advanced Science, 2024, v. 11, n. 18, p. 1, doi. 10.1002/advs.202305724
- By:
- Publication type:
- Article